Drugs / BNT168
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07698600 | Jul 2026 → Jan 2028 expected | HIV infectious disease | BioNTech SE | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BNT168 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07698600 ↗ |
| Modality | Vaccine | “RNA-based vaccine” NCT07698600 ↗ |
| Route | Intramuscular | “Intramuscular injection to be applied in the deltoid muscle, using the same non-dominant arm for all IMP injections” NCT07698600 ↗ |